In the last trading session, 1.04 million shares of the Mind Medicine Inc (NASDAQ:MNMD) were traded, and its beta was 2.36. Most recently the company’s share price was $6.78, and it changed around -$0.14 or -2.02% from the last close, which brings the market valuation of the company to $511.00M. MNMD currently trades at a discount to its 52-week high of $12.22, offering almost -80.24% off that amount. The share price’s 52-week low was $5.03, which indicates that the current value has risen by an impressive 25.81% since then. We note from Mind Medicine Inc’s average daily trading volume that its 10-day average is 1.02 million shares, with the 3-month average coming to 2.01 million.
Mind Medicine Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.36. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended MNMD as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Mind Medicine Inc is expected to report earnings per share of -0.37 for the current quarter.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD has showed a red trend with a performance of -2.02% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.05 on recent trading dayincreased the stock’s daily price by 3.83%. The company’s shares are currently down -2.59% year-to-date, but still up 5.12% over the last five days. On the other hand, Mind Medicine Inc (NASDAQ:MNMD) is -5.57% down in the 30-day period. We can see from the shorts that 11.81 million shares have been sold at a short interest cover period of 3.9 day(s).
The consensus price target as assigned by Wall Street analysts is $16, which translates to bulls needing to increase their stock price by 57.62% from its current value. Analyst projections state that MNMD is forecast to be at a low of $16 and a high of $16.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 10.40%.
MNMD Dividends
Mind Medicine Inc’s next quarterly earnings report is expected to be released on 2025-Mar-05.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.49% of Mind Medicine Inc shares, and 55.74% of them are in the hands of institutional investors. The stock currently has a share float of 56.59%. Mind Medicine Inc stock is held by 229.0 institutions, with COMMODORE CAPITAL LP being the largest institutional investor. By 2024-06-30, it held 9.9369% of the shares, which is about 7.15 million shares worth $51.52 million.
DEEP TRACK CAPITAL, LP, with 8.4879% or 6.1 million shares worth $44.01 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Russell 2000 ETF and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.17 shares worth $14.69 million, making up 2.87% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 988.95 shares worth around $6.71 million, which represents about 1.31% of the total shares outstanding.
